# Summa Health System – FDA Inspection, Mar 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/summa-health-system/67e5e470-47a6-4280-9176-66734b153418
Source feed: FDA_Inspections

> FDA inspection 1200440 of Summa Health System, March 21, 2023. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1200440
- Company Name: Summa Health System
- Inspection Date: 2023-03-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1261356 - 2025-02-11](https://www.keypedia.com/records/fda_inspections/summa-health-system/ac10336a-25f3-4e83-9d83-74f2e0cbdeaa)
- FDA Inspection 1079942 - 2019-02-14
- FDA Inspection 998458 - 2017-01-27
- FDA Inspection 919237 - 2015-03-24
- FDA Inspection 815176 - 2013-01-23

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/nancy-l-neiger/c3209528-eeb3-4a5f-88b1-f503798ed4c5)

Company: https://www.keypedia.com/companies/summa-health-system/8d7bf562-d4ca-4beb-ad6f-648e9888c0ef

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
